JEFFREY SOUZA: Open Payments
NPI 1831558196 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,045 in 23 payments from 10 companies in 2025. Trend: 2023 $1,456 · 2024 $2,346 · 2025 $1,045
Food & beverage: $1,045
| Company | Payments | Amount |
|---|---|---|
| Smith+Nephew, Inc. | 14 | $175 |
| Tactile Systems Technology Inc | 1 | $148 |
| Teva Pharmaceuticals USA, Inc. | 1 | $132 |
| Novo Nordisk Inc | 1 | $123 |
| AstraZeneca Pharmaceuticals LP | 1 | $123 |
| ALK-Abello, Inc | 1 | $119 |
| Alkermes, Inc. | 1 | $114 |
| Tandem Diabetes Care, Inc. | 1 | $73 |
| MIMEDX Group, Inc. | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
Products named: COLLAGENASE SANTYL, Flexitouch Plus, AJOVY, TEZSPIRE, VIVITROL, t:slim X2 Insulin Pump with Control-IQ, NUZYRA.
Industry payments across CA — which companies pay providers there.
